Aldosterone blockade and vascular calcification in hemodialysis patients.
Nitta
Kosaku
K
Akiba
Takashi
T
Nihei
Hiroshi
H
D000284:Administration, Oral; D000818:Animals; D002114:Calcinosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D000077545:Eplerenone; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000097:blood / Q000627:therapeutic use*; D053495:Osteopontin; D051381:Rats; D006435:Renal Dialysis; D012795:Sialoglycoproteins / Q000097:blood; D013148:Spironolactone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014652:Vascular Diseases / Q000097:blood / Q000188:drug therapy* / Q000209:etiology
D000451:Mineralocorticoid Receptor Antagonists; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; C506897:Spp1 protein, rat; D053495:Osteopontin; D013148:Spironolactone; D000077545:Eplerenone